{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:30:53Z","timestamp":1791318653229,"version":"4.3.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Colorectal cancer is a malignant tumor of the digestive system originating from abnormal cell proliferation in the colon or rectum, often leading to gastrointestinal symptoms and severe health issues. Nucleotide metabolism, which encompasses the synthesis of DNA and RNA, is a pivotal cellular biochemical process that significantly impacts both the progression and therapeutic strategies of colorectal cancer<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>For single-cell RNA sequencing (scRNA-seq), five functions were employed to calculate scores related to nucleotide metabolism. Cell developmental trajectory analysis and intercellular interaction analysis were utilized to explore the metabolic characteristics and communication patterns of different epithelial cells. These findings were further validated using spatial transcriptome RNA sequencing (stRNA-seq). A risk model was constructed using expression profile data from TCGA and GEO cohorts to optimize clinical decision-making. Key nucleotide metabolism-related genes (NMRGs) were functionally validated by further in vitro experiments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In both scRNA-seq and stRNA-seq, colorectal cancer (CRC) exhibited unique cellular heterogeneity, with myeloid cells and epithelial cells in tumor samples displaying higher nucleotide metabolism scores. Analysis of intercellular communication revealed enhanced signaling pathways and ligand-receptor interactions between epithelial cells with high nucleotide metabolism and fibroblasts. Spatial transcriptome sequencing confirmed elevated nucleotide metabolism states in the core region of tumor tissue. After identifying differentially expressed NMRGs in epithelial cells, a risk prognostic model based on four genes effectively predicted overall survival and immunotherapy outcomes in patients. High-risk group patients exhibited an immunosuppressive microenvironment and relatively poorer prognosis and responses to chemotherapy and immunotherapy. Finally, based on data analysis and a series of cellular functional experiments, ACOX1 and CPT2 were identified as novel therapeutic targets for CRC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this study, a comprehensive analysis of NMRGs in CRC was conducted using a combination of single-cell sequencing, spatial transcriptome sequencing, and high-throughput data. The prognostic model constructed with NMRGs shows potential as a standalone prognostic marker for colorectal cancer patients and may significantly influence the development of personalized treatment approaches for CRC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10142-024-01356-5","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T03:29:12Z","timestamp":1712719752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Targeting nucleotide metabolic pathways in colorectal cancer by integrating scRNA-seq, spatial transcriptome, and bulk RNA-seq data"],"prefix":"10.1007","volume":"24","author":[{"given":"Songyun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengpeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaheng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"1356_CR1","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ (2021) UCell: Robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J 19:3796\u20133798","journal-title":"Comput Struct Biotechnol J"},{"key":"1356_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-biodatasci-020722-091857","volume":"6","author":"D Aran","year":"2023","unstructured":"Aran D (2023) Single-Cell RNA Sequencing for Studying Human Cancers. Annu Rev Biomed Data Sci 6:1\u201322","journal-title":"Annu Rev Biomed Data Sci"},{"issue":"9","key":"1356_CR3","first-page":"1059","volume":"30","author":"V Barresi","year":"2015","unstructured":"Barresi V et al (2015) Histological grading in colorectal cancer: new insights and perspectives. Histol Histopathol 30(9):1059\u20131067","journal-title":"Histol Histopathol"},{"issue":"6024","key":"1356_CR4","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","volume":"331","author":"GL Beatty","year":"2011","unstructured":"Beatty GL et al (2011) CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331(6024):1612\u20131616","journal-title":"Science"},{"issue":"10","key":"1356_CR5","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/1078-0432.CCR-18-3309","volume":"25","author":"N Borcherding","year":"2019","unstructured":"Borcherding N et al (2019) Single-Cell Profiling of Cutaneous T-Cell Lymphoma Reveals Underlying Heterogeneity Associated with Disease Progression. Clin Cancer Res 25(10):2996\u20133005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1356_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P et al (2017) Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep 18(1):248\u2013262","journal-title":"Cell Rep"},{"issue":"6","key":"1356_CR7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamaoncol.2020.0910","volume":"6","author":"EX Chen","year":"2020","unstructured":"Chen EX et al (2020) Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study. JAMA Oncol 6(6):831\u2013838","journal-title":"JAMA Oncol"},{"key":"1356_CR8","doi-asserted-by":"crossref","unstructured":"Dutta S et al (2023) Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. Biology (Basel) 12(2)","DOI":"10.3390\/biology12020218"},{"issue":"1","key":"1356_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s42255-020-00317-z","volume":"3","author":"I Elia","year":"2021","unstructured":"Elia I, Haigis MC (2021) Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism. Nat Metab 3(1):21\u201332","journal-title":"Nat Metab"},{"issue":"1","key":"1356_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12967-022-03395-7","volume":"20","author":"Y Gao","year":"2022","unstructured":"Gao Y et al (2022) Single-cell N(6)-methyladenosine regulator patterns guide intercellular communication of tumor microenvironment that contribute to colorectal cancer progression and immunotherapy. J Transl Med 20(1):197","journal-title":"J Transl Med"},{"issue":"9","key":"1356_CR11","doi-asserted-by":"crossref","first-page":"e107468","DOI":"10.1371\/journal.pone.0107468","volume":"9","author":"P Geeleher","year":"2014","unstructured":"Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS One 9(9):e107468","journal-title":"PLoS One"},{"issue":"1","key":"1356_CR12","first-page":"1","volume":"50","author":"H Han","year":"2021","unstructured":"Han H, Feng F, Li H (2021) Research advances on epigenetics and cancer metabolism. Zhejiang Da Xue Xue Bao Yi Xue Ban 50(1):1\u201316","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"13","key":"1356_CR13","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y et al (2021) Integrated analysis of multimodal single-cell data. Cell 184(13):3573\u20133587 e29","journal-title":"Cell"},{"issue":"5","key":"1356_CR14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.coi.2008.07.002","volume":"20","author":"KJ Ishii","year":"2008","unstructured":"Ishii KJ, Akira S (2008) Potential link between the immune system and metabolism of nucleic acids. Curr Opin Immunol 20(5):524\u2013529","journal-title":"Curr Opin Immunol"},{"key":"1356_CR15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-015-0446-6","volume":"14","author":"R Kohnken","year":"2015","unstructured":"Kohnken R, Kodigepalli KM, Wu L (2015) Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications. Mol Cancer 14:176","journal-title":"Mol Cancer"},{"issue":"6","key":"1356_CR16","first-page":"705","volume":"25","author":"M Koundinya","year":"2018","unstructured":"Koundinya M et al (2018) Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers. Cell. Chem Biol 25(6):705\u2013717 e11","journal-title":"Chem Biol"},{"issue":"6","key":"1356_CR17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT et al (2012) The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28(6):882\u2013883","journal-title":"Bioinformatics"},{"issue":"1","key":"1356_CR18","doi-asserted-by":"crossref","first-page":"112892","DOI":"10.1016\/j.yexcr.2021.112892","volume":"409","author":"H Li","year":"2021","unstructured":"Li H et al (2021) CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS\/Wnt\/beta-catenin-induced glycolytic metabolism. Exp Cell Res 409(1):112892","journal-title":"Exp Cell Res"},{"issue":"10","key":"1356_CR19","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1016\/j.crad.2023.06.012","volume":"78","author":"M Li","year":"2023","unstructured":"Li M et al (2023) CT-based radiomics nomogram for the preoperative prediction of microsatellite instability and clinical outcomes in colorectal cancer: a multicentre study. Clin Radiol 78(10):e741\u2013e751","journal-title":"Clin Radiol"},{"key":"1356_CR20","doi-asserted-by":"crossref","first-page":"110267","DOI":"10.1016\/j.cellsig.2022.110267","volume":"92","author":"F Liu","year":"2022","unstructured":"Liu F et al (2022b) Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer. Cell Signal 92:110267","journal-title":"Cell Signal"},{"key":"1356_CR21","doi-asserted-by":"crossref","first-page":"828330","DOI":"10.3389\/fimmu.2022.828330","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z et al (2022a) Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options. Front Immunol 13:828330","journal-title":"Front Immunol"},{"issue":"9","key":"1356_CR22","doi-asserted-by":"crossref","first-page":"13349","DOI":"10.18632\/aging.202962","volume":"13","author":"J Ma","year":"2021","unstructured":"Ma J et al (2021) Emerging roles of nucleotide metabolism in cancer development: progress and prospect. Aging (Albany NY) 13(9):13349\u201313358","journal-title":"Aging (Albany NY)"},{"issue":"7693","key":"1356_CR23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S et al (2018) TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548","journal-title":"Nature"},{"issue":"4","key":"1356_CR24","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","volume":"34","author":"O Meurette","year":"2018","unstructured":"Meurette O, Mehlen P (2018) Notch Signaling in the Tumor Microenvironment. Cancer Cell 34(4):536\u2013548","journal-title":"Cancer Cell"},{"issue":"5","key":"1356_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen NJ, Singh PK (2023) Nucleotide metabolism: a pan-cancer metabolic dependency. Nat Rev Cancer 23(5):275\u2013294","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1356_CR26","doi-asserted-by":"crossref","first-page":"e2253","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri E, Santoro MM (2016) ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis 7(6):e2253","journal-title":"Cell Death Dis"},{"issue":"1","key":"1356_CR27","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J et al (2022) Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun 13(1):1742","journal-title":"Nat Commun"},{"issue":"4","key":"1356_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0168-9525(97)01103-7","volume":"13","author":"M Rebhan","year":"1997","unstructured":"Rebhan M et al (1997) GeneCards: integrating information about genes, proteins and diseases. Trends Genet 13(4):163","journal-title":"Trends Genet"},{"issue":"1","key":"1356_CR29","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1038\/s41467-018-07232-8","volume":"9","author":"SR Rosario","year":"2018","unstructured":"Rosario SR et al (2018) Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. Nat Commun 9(1):5330","journal-title":"Nat Commun"},{"issue":"8","key":"1356_CR30","doi-asserted-by":"crossref","first-page":"108421","DOI":"10.1016\/j.celrep.2020.108421","volume":"33","author":"S Shen","year":"2020","unstructured":"Shen S et al (2020) Melanoma Persister Cells Are Tolerant to BRAF\/MEK Inhibitors via ACOX1-Mediated Fatty Acid Oxidation. Cell Rep 33(8):108421","journal-title":"Cell Rep"},{"issue":"8","key":"1356_CR31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.trecan.2023.04.008","volume":"9","author":"DD Shi","year":"2023","unstructured":"Shi DD et al (2023) Emerging roles of nucleotide metabolism in cancer. Trends Cancer 9(8):624\u2013635","journal-title":"Trends Cancer"},{"issue":"3","key":"1356_CR32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1356_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13059-022-02663-5","volume":"23","author":"J Tanevski","year":"2022","unstructured":"Tanevski J et al (2022) Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. Genome Biol 23(1):97","journal-title":"Genome Biol"},{"issue":"2","key":"1356_CR34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3892\/or.2015.4470","volume":"35","author":"J Tang","year":"2016","unstructured":"Tang J et al (2016) CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE\/TGF-alpha\/EGFR pathway in hypoxic androgen-independent prostate cancer cells. Oncol Rep 35(2):1153\u20131162","journal-title":"Oncol Rep"},{"issue":"2","key":"1356_CR35","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.immuni.2019.08.004","volume":"51","author":"V Thorsson","year":"2019","unstructured":"Thorsson V et al (2019) The Immune Landscape of Cancer. Immunity 51(2):411\u2013412","journal-title":"Immunity"},{"issue":"6282","key":"1356_CR36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I et al (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352(6282):189\u2013196","journal-title":"Science"},{"key":"1356_CR37","doi-asserted-by":"crossref","first-page":"215713","DOI":"10.1016\/j.canlet.2022.215713","volume":"539","author":"A Tyagi","year":"2022","unstructured":"Tyagi A, Wu SY, Watabe K (2022) Metabolism in the progression and metastasis of brain tumors. Cancer Lett 539:215713","journal-title":"Cancer Lett"},{"issue":"10","key":"1356_CR38","doi-asserted-by":"crossref","first-page":"e14123","DOI":"10.15252\/emmm.202114123","volume":"13","author":"F Uhlitz","year":"2021","unstructured":"Uhlitz F et al (2021) Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer. EMBO Mol Med 13(10):e14123","journal-title":"EMBO Mol Med"},{"issue":"5","key":"1356_CR39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10585-015-9719-0","volume":"32","author":"LG van der Geest","year":"2015","unstructured":"van der Geest LG et al (2015) Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis 32(5):457\u2013465","journal-title":"Clin Exp Metastasis"},{"key":"1356_CR40","doi-asserted-by":"crossref","unstructured":"Wang X et al (2019) Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells. Sci Transl Med 11(504)","DOI":"10.1126\/scitranslmed.aau4972"},{"issue":"1","key":"1356_CR41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-022-01263-x","volume":"15","author":"HL Wu","year":"2022","unstructured":"Wu HL et al (2022a) Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy. J Hematol Oncol 15(1):45","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1356_CR42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y et al (2022b) Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. Cancer Discov 12(1):134\u2013153","journal-title":"Cancer Discov"},{"issue":"1","key":"1356_CR43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L et al (2021) The cancer metabolic reprogramming and immune response. Mol Cancer 20(1):28","journal-title":"Mol Cancer"},{"key":"1356_CR44","doi-asserted-by":"crossref","first-page":"1076883","DOI":"10.3389\/fimmu.2022.1076883","volume":"13","author":"J Xie","year":"2022","unstructured":"Xie J et al (2022) Advances in artificial intelligence to predict cancer immunotherapy efficacy. Front Immunol 13:1076883","journal-title":"Front Immunol"},{"key":"1356_CR45","doi-asserted-by":"crossref","first-page":"1188760","DOI":"10.3389\/fimmu.2023.1188760","volume":"14","author":"J Xiong","year":"2023","unstructured":"Xiong J et al (2023) Revolutionizing anti-tumor therapy: unleashing the potential of B cell-derived exosomes. Front Immunol 14:1188760","journal-title":"Front Immunol"},{"issue":"23","key":"1356_CR46","doi-asserted-by":"crossref","first-page":"6575","DOI":"10.1158\/0008-5472.CAN-18-0689","volume":"78","author":"L Xu","year":"2018","unstructured":"Xu L et al (2018) TIP: A Web Server for Resolving Tumor Immunophenotype Profiling. Cancer Res 78(23):6575\u20136580","journal-title":"Cancer Res"},{"key":"1356_CR47","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K et al (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612","journal-title":"Nat Commun"},{"issue":"20","key":"1356_CR48","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1158\/1078-0432.CCR-16-2598","volume":"23","author":"C Zhang","year":"2017","unstructured":"Zhang C et al (2017) Tumor Purity as an Underlying Key Factor in Glioma. Clin Cancer Res 23(20):6279\u20136291","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1356_CR49","doi-asserted-by":"crossref","first-page":"e0245876","DOI":"10.1371\/journal.pone.0245876","volume":"16","author":"H Zhang","year":"2021","unstructured":"Zhang H et al (2021c) The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT \/ Cyclin D signaling. PLoS One 16(2):e0245876","journal-title":"PLoS One"},{"issue":"1","key":"1356_CR50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41392-022-00960-w","volume":"7","author":"L Zhang","year":"2022","unstructured":"Zhang L et al (2022) Clinical and translational values of spatial transcriptomics. Signal Transduct Target Ther 7(1):111","journal-title":"Signal Transduct Target Ther"},{"key":"1356_CR51","doi-asserted-by":"crossref","first-page":"1196372","DOI":"10.3389\/fendo.2023.1196372","volume":"14","author":"P Zhang","year":"2023","unstructured":"Zhang P et al (2023a) Integrating multiple machine learning methods to construct glutamine metabolism-related signatures in lung adenocarcinoma. Front Endocrinol (Lausanne) 14:1196372","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1356_CR52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41421-022-00515-x","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q et al (2023b) Reprogramming of palmitic acid induced by dephosphorylation of ACOX1 promotes beta-catenin palmitoylation to drive colorectal cancer progression. Cell Discov 9(1):26","journal-title":"Cell Discov"},{"issue":"11","key":"1356_CR53","first-page":"812","volume":"17","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014) Advances in the relationship between tumor cell metabolism and tumor metastasis. Zhongguo Fei Ai Za Zhi 17(11):812\u2013818","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"1356_CR54","doi-asserted-by":"crossref","first-page":"101131","DOI":"10.1016\/j.molmet.2020.101131","volume":"44","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021a) LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases. Mol Metab 44:101131","journal-title":"Mol Metab"},{"key":"1356_CR55","doi-asserted-by":"crossref","unstructured":"Zhang, Y., et al., CellCall: integrating paired ligand-receptor and transcription factor activities for cell-cell communication. Nucleic Acids Res, 2021b. 49(15): p. 8520-8534.","DOI":"10.1093\/nar\/gkab638"},{"key":"1356_CR56","doi-asserted-by":"crossref","first-page":"1196892","DOI":"10.3389\/fimmu.2023.1196892","volume":"14","author":"Z Zhao","year":"2023","unstructured":"Zhao Z et al (2023) Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells. Front Immunol 14:1196892","journal-title":"Front Immunol"},{"issue":"8","key":"1356_CR57","first-page":"689","volume":"23","author":"Y Zheng","year":"2020","unstructured":"Zheng Y et al (2020) Research Progress on Exosome in Malignant Tumors. Zhongguo Fei Ai Za Zhi 23(8):689\u2013694","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"4","key":"1356_CR58","first-page":"425","volume":"39","author":"HX Zhou","year":"2021","unstructured":"Zhou HX et al (2021) circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p\/acyl-CoA oxidase 1 axis. Hua Xi Kou Qiang Yi Xue Za Zhi 39(4):425\u2013433","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"issue":"1","key":"1356_CR59","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y et al (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10(1):1523","journal-title":"Nat Commun"},{"issue":"3","key":"1356_CR60","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1158\/0008-5472.CAN-22-2145","volume":"83","author":"S Zou","year":"2023","unstructured":"Zou S et al (2023) CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer. Cancer Res 83(3):414\u2013427","journal-title":"Cancer Res"}],"container-title":["Functional &amp; Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-024-01356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-024-01356-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-024-01356-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:25:16Z","timestamp":1714472716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-024-01356-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1356"],"URL":"https:\/\/doi.org\/10.1007\/s10142-024-01356-5","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"72"}}